Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gynecologic 1Dermatologic 1Breast 1

Conditions

Melanoma 3Lung Neoplasms 3Colitis 3Urogenital Neoplasms 2Solid Carcinoma 2Diarrhea 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Advanced Gastric Cancer 1

Interventions

pembrolizumab 5fludarabine 2enfortumab vedotin 2darolutamide 2atezolizumab 2aldesleukin 2Riluzole 2Nivolumab 2Mitomycin 2Fecal Microbiota Transplantation 2Cyclophosphamide 2vedolizumab 1relatlimab 1prednylidene 1olaparib 1lenvatinib 1deltacortene 1cabozantinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Tadalafil 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Rivaroxaban 1Radiosurgery 1Radiation Dose Hypofractionation 1Pregnancy Tests 1Prednisone 1Practice Guidelines as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Urogenital Neoplasms × Fecal Microbiota Transplantation × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡